WordNet

releasing or activated by acetylcholine or a related compound

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2015/12/26 13:12:49」(JST)

wiki en

[Wiki en表示]

The N,N,N-trimethylethanolammonium cation, with an undefined counteranion, X⁻

Acetylcholine

In general, the word choline refers to the various quaternary ammonium salts containing the N,N,N-trimethylethanolammonium cation. Found in most animal tissues, choline is a primary component of the neurotransmitter acetylcholine and functions with inositol as a basic constituent of lecithin. It prevents fat deposits in the liver and facilitates the movement of fats into the cells. The richest sources of choline are liver, kidney, brain, wheat germ, brewer's yeast, and egg yolk. Neurologically, cholinergic is the abbreviated term referring to acetylcholine.^[1] The parasympathetic nervous system, which uses acetylcholine almost exclusively to send its messages, is said to be almost entirely cholinergic. Neuromuscular junctions, preganglionic neurons of the sympathetic nervous system, the basal forebrain, and brain stem complexes are also cholinergic. In addition, the receptor for the merocrine sweat glands are also cholinergic, since acetylcholine is released from postganglionic sympathetic neurons.

In neuroscience and related fields, the term cholinergic is used in these related contexts:

A substance (or ligand) is cholinergic if it is capable of producing, altering, or releasing acetylcholine ("indirect-acting") or mimicking its behaviour at one or more of the body's acetylcholine receptor types ("direct-acting"). Such mimics are called parasympathomimetic drugs or cholinomimetic drugs.
A receptor is cholinergic if it uses acetylcholine as its neurotransmitter.^[2]
A synapse is cholinergic if it uses acetylcholine as its neurotransmitter.

Cholinergic drug

Structure activity relationship for cholinergic drugs^[3]

A molecule must possess a nitrogen atom capable of bearing a positive charge, preferably a quaternary ammonium salt.
For maximum potency, the size of the alkyl groups substituted on the nitrogen should not exceed the size of a methyl group.
The molecule should have an oxygen atom, preferably an ester-like oxygen capable of participating in a hydrogen bond.
A two-carbon unit should occur between the oxygen atom and the nitrogen atom.

Cholinergic hypothesis of Alzheimer's disease

As researchers began to focus on neurotransmitter imbalances as a cause of Alzheimer's disease (AD), the cholinergic hypothesis was proposed. The hypothesis states that a possible cause of AD is the reduced synthesis of acetylcholine, a neurotransmitter involved in both memory and learning, two important components of AD. Many current drug therapies for AD are centered around the cholinergic hypothesis, although not all have been effective. Studies performed in the 1980s demonstrated significant impairment of cholinergic markers in Alzheimer’s patients.^[4]

Thus it was proposed that degeneration of cholinergic neurons in the basal forebrain and the associated loss of cholinergic neurotransmission in the cerebral cortex and other areas contributed significantly to the deterioration in cognitive function seen in patients with Alzheimer’s disease^[5]

Further studies on the cholinergic system and AD demonstrated acetylcholine plays a role in learning and memory. Scopolamine, an anticholinergic drug, was used to block cholinergic activity in young adults and induce memory impairments similar to those present in the elderly. The memory impairments were reversed when treated with physostigmine, a cholinergic agonist. However, reversing memory impairments in AD patients may not be this easy due to permanent changes in brain structure.^[6]

When young adults perform memory and attention tasks, brain activation patterns are balanced between the frontal and occipital lobes, creating a balance between bottom-up and top-down processing. Normal cognitive aging may affect long term and working memory, though the cholinergic system and cortical areas maintain performance through functional compensation. Adults with AD presenting with dysfunction of the cholinergic system are not able to compensate for long-term and working memory deficits.^[7]

AD is currently treated by increasing acetylcholine concentration by using acetylcholinesterase inhibitors to inhibit acetylcholinesterase from breaking down acetylcholine. Current acetylcholinesterase inhibitors approved in the United States by the FDA to treat Alzheimer’s include donepezil, rivastigmine, and galantamine. These drugs work to increase the levels of acetylcholine and subsequently increase the function of neural cells.^[8] However, not all treatments based upon the cholinergic hypothesis have been successful in treating the symptoms or slowing the progression of AD.^[9] Therefore, a disruption to the cholinergic system has been proposed as a consequence of AD rather than a direct cause.^[8]

References

^ "Definition: cholinergic from Online Medical Dictionary".
^ "Dorlands Medical Dictionary:cholinergic receptors".
^ Medicinal Chemistry of Adrenergics and Cholinergics
^ Contestabile, A. (August 2011). "The history of the cholinergic hypothesis". Behavioral Brain Research 221 (2): 334–340. doi:10.1016/j.bbr.2009.12.044.
^ Bartus RT, Dean RL, Beer B (1982). "The cholinergic hypothesis of geriatric memory dysfunction". Science 217: 408–417. doi:10.1126/science.7046051.
^ Craig, L.A., Hong, N.S., McDonald, R.J. (May 2011). "Revisiting the cholinergic hypothesis in the development of Alzheimer's disease". Neuroscience & Behavioral Reviews 35 (6): 1397–1409. doi:10.1016/j.neubiorev.2011.03.001.
^ Mapstone, M, Dickerson, K, Duffy, C.J. (2008). "Distinct mechanisms of impairment in cognitive ageing and Alzheimer’s disease.". Brain 131: 1618–1629. doi:10.1093/brain/awn064.
^ ^a ^b Tabet, N. (July 2008). "Acetylcholinesterase inhibitors for Alzheimer’s disease: anti-inflammatories in acetylcholine clothing.". Age Ageing 35 (4): 336–338. doi:10.1093/ageing/afl027.
^ Martorana, A, Esposito, Z, Koch, G. (August 2010). "Beyond the Cholinergic Hypothesis: Do Current Drugs Work in Alzheimer’s Disease?". CNS Neuroscience & Therapeutics 16 (4): 235–245. doi:10.1111/j.1755-5949.2010.00175.

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 有機リン剤およびカルバメート中毒 organophosphate and carbamate poisoning
2. 重症筋無力症患者に対する麻酔 anesthesia for the patient with myasthenia gravis
3. 抗コリン剤中毒 anticholinergic poisoning
4. 寝汗がみられる患者に対するアプローチ approach to the patient with night sweats
5. キノコ中毒の臨床症状および評価 clinical manifestations and evaluation of mushroom poisoning

English Journal

Is encroachment of the carotid termination into the substantia innominata associated with its atrophy and cognition in Alzheimer's disease?

Gao FQ, Pettersen JA, Bocti C, Nestor SM, Kiss A, Black SE.SourceLinda C. Campbell Cognitive Neurology Research Unit, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada; Heart and Stroke Foundation Centre for Stroke Recovery, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada; Brain Science Research Program, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada. Electronic address: fgao@sri.utoronto.ca.
Neurobiology of aging.Neurobiol Aging.2013 Jul;34(7):1807-14. doi: 10.1016/j.neurobiolaging.2013.01.009. Epub 2013 Feb 13.
The internal carotid artery termination (CAT) ends in a T-shaped bifurcation just below the substantia innominata (SI), which contains cognitively strategic cholinergic neurons and undergoes atrophy in Alzheimer's disease (AD). This study investigated whether an elongated CAT with possible resulting
PMID 23414670

The DOPA decarboxylase (DDC) gene is associated with alerting attention.

Zhu B, Chen C, Moyzis RK, Dong Q, Chen C, He Q, Li J, Li J, Lei X, Lin C.SourceState Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University, China.
Progress in neuro-psychopharmacology & biological psychiatry.Prog Neuropsychopharmacol Biol Psychiatry.2013 Jun 3;43:140-5. doi: 10.1016/j.pnpbp.2012.12.020. Epub 2012 Dec 29.
DOPA decarboxylase (DDC) is involved in the synthesis of dopamine, norepinephrine and serotonin. It has been suggested that genes involved in the dopamine, norepinephrine, and cholinergic systems play an essential role in the efficiency of human attention networks. Attention refers to the cognitive
PMID 23276884

Muscarinic cholinergic receptor M1 in the rat basolateral amygdala: Ultrastructural localization and synaptic relationships to cholinergic axons.

Muller JF, Mascagni F, Zaric V, McDonald AJ.SourceDepartment of Pharmacology, Physiology and Neuroscience, University of South Carolina School of Medicine, Columbia, South Carolina 29208.
The Journal of comparative neurology.J Comp Neurol.2013 Jun 1;521(8):1743-59. doi: 10.1002/cne.23254.
Muscarinic neurotransmission in the anterior basolateral amygdalar nucleus (BLa) mediated by the M1 receptor (M1R) is critical for memory consolidation. Although knowledge of the subcellular localization of M1R in the BLa would contribute to an understanding of cholinergic mechanisms involved in mne
PMID 23559406

Japanese Journal

症例直腸癌術後にdistigmine bromideによるコリン作動性クリーゼと中毒性巨大結腸症を併発した1例

外科 = Surgey : 臨床雑誌 78(2), 190-193, 2016-02
NAID 40020719825

発汗障害とコリン性蕁麻疹

臨床免疫・アレルギー科 = Clinical immunology & allergology 64(5), 501-505, 2015-11
NAID 40020656779

症例報告発汗回復に伴い点状膨疹出現範囲が移動した減汗性コリン性蕁麻疹の1例

臨床皮膚科 = Japanese journal of clinical dermatology 69(6), 374-378, 2015-05
NAID 40020477192

Related Pictures

Pharmacology cholinergic agonist 17+ best images about nurse life. on Pinterest | Endocrine system, Pharmacology and nicotinic, muscarinic, cholinergic - Google Search | Basic classes | Pinterest | Search cholinergic receptors - Pertamini.co Cholinergic receptors,funtion and its clinical application Anticholinergic | tenderness.co adrenergic cholinergic flow chart: fight, rest, sludge, dry | Nursing | Pharmacology

★リンクテーブル★

リンク元	「muscarinic」「cholinomimetic」「cholinergic drug」「cholinergic agonist」「cholinergic agent」
拡張検索	「nonadrenergic noncholinergic relaxation」「non-cholinergic, non-adrenergic nerve」「cholinergic neuron」「cholinergic differentiation factor」